ArticleBMJ public health2025

Disparities in the access to immune checkpoint inhibitors approved in the United States, the European Union and mainland China: a serial cross-sectional study.

Jia-Xin Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.